LDL Cholesterol Calculator

A standard lipid panel reports four core numbers: total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. Each one tells a different part of the story, and looking at them together matters more than any single value in isolation.

Total cholesterolis the sum of all cholesterol in your bloodstream — both the “good” high-density lipoprotein (HDL) and the atherogenic lipoproteins such as LDL and VLDL. A total cholesterol below 200 mg/dL is generally considered desirable, but the composition matters. A person with a total of 210 mg/dL made up mostly of HDL is in a very different situation than someone with the same total made up mostly of LDL.

HDL cholesterolis the “good” cholesterol. HDL particles reverse-transport cholesterol from artery walls back to the liver for disposal. Higher HDL is associated with lower cardiovascular risk, with most guidelines recommending HDL above 40 mg/dL for men and above 50 mg/dL for women. Lifestyle drivers that raise HDL include regular aerobic exercise, moderate weight loss, quitting smoking, and replacing saturated fat with monounsaturated fats like olive oil.

LDL cholesterolis the “bad” cholesterol. LDL particles deliver cholesterol from the liver to tissues that need it. When LDL particles become oxidized or circulate at high concentrations for long periods, they infiltrate artery walls and contribute to atherosclerotic plaque. LDL is the primary target of most cholesterol-lowering therapy because long-term LDL exposure is causally linked to heart attacks and strokes.

Triglycerides are the storage form of fat in your blood. After a meal, excess calories from any source — especially refined carbohydrates and alcohol — are packaged into triglycerides. Very-low-density lipoproteins (VLDL) carry them through the bloodstream. Fasting triglycerides below 150 mg/dL are considered normal. Persistently high triglycerides (above 200 mg/dL) are a marker for metabolic dysfunction and are independently associated with cardiovascular risk.

Looking at non-HDL cholesterol (Total minus HDL) often gives a cleaner picture of atherogenic burden than LDL alone, because it captures every lipoprotein particle that can drive plaque formation — LDL, VLDL, IDL, and lipoprotein(a). Some clinicians consider non-HDL and apolipoprotein B (apoB) better risk markers than LDL, especially in people with elevated triglycerides.

William T. Friedewald and colleagues published their now-famous equation in 1972. The goal was practical: most labs could measure total cholesterol, HDL, and triglycerides directly and inexpensively, but a direct LDL measurement required ultracentrifugation that was slow, expensive, and not widely available. Friedewald’s insight was that VLDL cholesterol is approximately one-fifth of the triglyceride concentration when values are expressed in mg/dL, so LDL could be inferred by subtraction.

The formula is straightforward:

LDL (mg/dL) = Total Cholesterol − HDL − (Triglycerides / 5)

If your values are in mmol/L, the equivalent divisor for triglycerides is 2.2 (or convert everything to mg/dL first, which this calculator does for you). The Friedewald equation remains the most widely used LDL estimation method in clinical practice worldwide, but it has known limitations.

Where Friedewald breaks down: the triglyceride divided by 5 assumption holds reasonably well when triglycerides are under about 400 mg/dL and LDL is in the mid-range. It underestimates LDL when triglycerides are high and overestimates LDL when triglycerides are very low. At triglycerides above 400 mg/dL, the equation should not be used at all — the relationship between VLDL and triglycerides becomes nonlinear. In those cases, clinicians order a direct LDL measurement or use the Martin-Hopkins equation, which uses an adjustable divisor based on triglyceride and non-HDL levels and has been shown to be more accurate at LDL values below 70 mg/dL.

For most people with typical lipid values, Friedewald is accurate enough for routine clinical decisions. Just know that a single calculated value should be interpreted in context — alongside trends over time, your overall risk factors, and your clinician’s judgment.

Magnesium is the fourth most abundant mineral in the human body and a cofactor for more than 300 enzymatic reactions, including many that directly affect cardiovascular function. Despite its importance, an estimated 50% of U.S. adults fall short of the recommended daily intake, and subclinical magnesium insufficiency is common — especially among people with type 2 diabetes, metabolic syndrome, or chronic stress.

Magnesium is essential for normal cardiac rhythm, vascular tone, and endothelial function. It acts as a natural calcium channel blocker in vascular smooth muscle, promoting healthy blood pressure. It is also a cofactor for HMG-CoA reductase (the rate-limiting enzyme in cholesterol synthesis and the same target as statin medications) and for lecithin–cholesterol acyltransferase (LCAT), which helps HDL particles mature and carry cholesterol back to the liver.

Multiple meta-analyses of randomized controlled trials have looked at magnesium supplementation and lipid profiles. In a 2017 meta-analysis published in Nutrition Journalcovering over 1,500 participants, magnesium supplementation was associated with modest but statistically significant reductions in LDL cholesterol and triglycerides and a small increase in HDL. Effects were most pronounced in people with low baseline magnesium status, diabetes, or insulin resistance.

Low magnesium status has also been linked to increased risk of hypertension, arterial stiffness, atrial fibrillation, and sudden cardiac death in large observational cohorts. A 2013 meta-analysis in the American Journal of Clinical Nutrition pooling over 310,000 participants found that higher dietary magnesium intake was associated with a significantly lower risk of cardiovascular disease.

The form of magnesium matters. Magnesium oxide is poorly absorbed (roughly 4% bioavailability) and is used mainly as a laxative. Chelated forms such as magnesium bisglycinate bind magnesium to the amino acid glycine, producing much better absorption and a gentler effect on the digestive system. Bisglycinate is often preferred when the goal is to correct a deficiency rather than treat constipation.

The connection between psychological stress and cardiovascular disease is no longer controversial. Chronic stress acts on lipid metabolism through several overlapping pathways, and the common thread is cortisol — your body’s primary stress hormone.

When you experience stress, the hypothalamic-pituitary-adrenal (HPA) axis triggers cortisol release from the adrenal glands. Acutely, cortisol mobilizes energy: it signals the liver to release glucose, breaks down fat stores into free fatty acids, and increases VLDL production. In a short-term “fight or flight” context, this is adaptive. The problem arises when cortisol remains elevated for weeks, months, or years.

Chronically elevated cortisol has been associated with dyslipidemia in multiple population studies — higher LDL, higher triglycerides, and lower HDL. A frequently cited 2005 study in the Psychosomatic Medicine journal found that work-stress scores in middle-aged adults correlated independently with an adverse lipid profile, even after adjusting for diet, exercise, and body weight. A 2014 systematic review in Neuroscience & Biobehavioral Reviews confirmed the link between HPA-axis dysregulation and features of metabolic syndrome, including cholesterol changes.

Stress also drives downstream behaviors that compound the effect: worse sleep, higher consumption of refined carbs and alcohol, less time for exercise, and reduced adherence to medications. In other words, stress doesn’t just alter your biochemistry; it quietly reshapes the habits that protect your heart.

This is why stress management is increasingly viewed as a cardiovascular intervention, not just a mental-health one. Mindfulness-based stress reduction, cognitive behavioral therapy, structured breathing practices, and regular aerobic exercise have all shown cortisol-lowering effects in randomized trials. Adaptogenic herbs such as ashwagandha (Withania somnifera) have also been studied; a 2019 randomized trial in the Medicine journal found that 240 mg/day of a standardized ashwagandha extract reduced morning cortisol levels by roughly 23% over eight weeks compared with placebo, alongside meaningful improvements in self-reported stress and sleep quality.

No single intervention is a magic bullet for cholesterol, but the evidence base for lifestyle-driven improvements is deep. Here are the levers with the strongest research behind them.

Eat more soluble fiber.Soluble fiber binds bile acids in the gut, forcing the liver to pull LDL from the bloodstream to make more. Oats, beans, lentils, barley, apples, pears, and psyllium are standouts. Just 5–10 grams of soluble fiber per day can reduce LDL by 5–11 mg/dL, according to pooled clinical trial data.

Prioritize unsaturated fats. Replacing saturated fat (butter, fatty red meat, processed meat, coconut oil) with monounsaturated and polyunsaturated fats (olive oil, avocados, nuts, fatty fish, seeds) lowers LDL without lowering HDL. The Mediterranean diet pattern, which emphasizes this swap, has some of the strongest evidence of any dietary pattern for cardiovascular outcomes, including a 30% relative risk reduction in major cardiovascular events in the landmark PREDIMED trial.

Exercise regularly. Both aerobic and resistance training improve lipid profiles. The American Heart Association recommends at least 150 minutes per week of moderate-intensity aerobic activity or 75 minutes of vigorous activity. Regular exercise raises HDL, modestly lowers triglycerides, and improves LDL particle size (a shift from small-dense LDL to large-buoyant LDL is favorable).

Sleep well. Sleep deprivation and untreated sleep apnea are independently linked to adverse lipid profiles. A 2016 study in Scientific Reports found that adults sleeping less than six hours per night had significantly higher LDL and triglycerides than those getting seven to eight hours. Prioritizing sleep quality and consistency is a simple but underrated cholesterol intervention.

Address magnesium status. If your diet is low in leafy greens, nuts, seeds, and whole grains — or if you have insulin resistance or use proton pump inhibitors for long periods — your magnesium status may be suboptimal. Correcting a deficiency through a well-absorbed form such as magnesium bisglycinate may modestly improve lipid numbers and supports many other cardiovascular functions, including blood pressure and heart rhythm.

Manage stress. Consistent stress-reduction practices — mindfulness, paced breathing, time outdoors, social connection — bring cortisol down, which in turn supports better lipid numbers and, just as importantly, the daily habits that keep your heart healthy. Adaptogens such as ashwagandha can be a useful adjunct for people with chronically elevated stress, though they are not a substitute for behavioral change.

Get enough quality sleep consistently. Going to bed and waking up at the same time reinforces healthy circadian rhythms, which regulate the enzymes that handle cholesterol synthesis and clearance. Tools that support sleep onset — including transdermal magnesium and melatonin delivery — can help you hit a consistent bedtime without middle-of-the-night awakenings that fragment sleep.

Finally, remember that lifestyle change and medication are not in opposition. Many people benefit from both. Calculated LDL is a single snapshot; what matters is the trajectory of your numbers over months and years, evaluated in the context of your full cardiovascular risk profile. Use this calculator as a tool for understanding and conversation with your clinician — not as a substitute for professional care.